Fundraising Fox
Surgivance
1 known investors
Find your way into Surgivance
Sign up to see every warm intro you have to Surgivance
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Surgivance team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Surgivance develops digital pathology imaging technology for analyzing tissue samples with rapid image capture and without calibration requirements. The company serves pathology laboratories and medical professionals in the healthcare diagnostics field.
Investors · 1
Portland Seed Fundlisted by Portland Seed FundPortland · $25K
How we know: the VCSheet dataset · Not right? Tell us
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $1M |
| National Science Foundation | Phase I | 2022 | $256K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $492.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Surgivance do?
- Surgivance develops digital pathology imaging technology for analyzing tissue samples with rapid image capture and without calibration requirements. The company serves pathology laboratories and medical professionals in the healthcare diagnostics field.
- Who are Surgivance's investors?
- Surgivance's investors include Portland Seed Fund.